phase i study of ioa-244 in follicular lymphoma
Published 2 years ago • 166 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
0:56
cnty-101 in follicular lymphoma: a case study from the elipse-1 trial
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:04
phase i/ii study of bosutinib in newly diagnosed & resistant/intolerant pediatric patients with cml
-
2:18
update on phase i/ii study of glofitamab monotherapy in r/r mcl
-
3:21
a phase i trial of hu8f4, an anti-pr1/hla-a2 monoclonal antibody, in r/r myeloid malignancies
-
2:43
insights into phase i/ii study assessing fixed-duration glofitamab treatment for r/r lbcl
-
5:30
glofitamab in r/r dlbcl: updated safety and efficacy data
-
3:22
emerging aml treatments: what is menin inhibitor therapy?
-
4:46
glofitamab induces durable complete remissions in patients with relapsed large b-cell lymphoma
-
1:44
insights into the phase ii tidal study
-
6:43
phase ii study of response-adapted ultra-low dose radiotherapy for b-cell lymphoma
-
3:46
a phase ib/ii trial of sonrotoclax plus dexamethasone in patients with r/r mm harboring t(11;14)
-
3:46
overview of a phase i study of ono/gs-4059 in relapsed and refractory mature b-cell malignancies
-
58:01
an introduction to using the fop treatment guidelines
-
2:24
first-in-human study of tti-621 in r/r hematologic malignancies
-
1:37
long-term follow-up from a phase ii trial of olutasidenib in idh1-mutated aml
-
2:52
long-term evaluation of luspatercept in esa-intolerant/refractory lr-mds: medalist follow-up study
-
1:45
a phase ii study of elritercept for lower-risk mds
-
12:17
updated iv and sc results from a phase i dose escalation study of forimtamig with rrmm patients
-
2:10
a study investigating the incidence of treatment-emergent autoimmune cytopenias in cll